Being the world's first company that produces labware from plant-based plastic, we empower the biopharmaceutical industry to embrace sustainability. Through pioneering systems like the CellScrew®, we aim to address the bottleneck in biopharmaceutical production by enhancing production capacity, ultimately increasing patient access and affordability to life-changing novel therapies.
Sustainability in the healthcare sector
With a total amount of two gigatons of carbon dioxide equivalent, the global healthcare sector is responsible for 4,4 % of global carbon emissions. By replacing non-renewable plastic with plant-based plastic, we provide the industry with an efficient tool to take action in reducing its climate impact.
Automation in bioprocessing
We develop systems that drive the automation of adherent cell culture.
In the growing field of cell and gene therapies, there is a pressing demand for automated solutions that can streamline and expedite processes, particularly because the development of these innovative therapies relies on small batch sizes. In a growing market, where skilled personnel is limited, automation is key to successful scale-up.
Affordability & accessibility of treatments
Innovative systems like CellScrew® increase the accessibility and affordability of the most advanced therapies for patients.
By increasing efficiency and reducing costs, patients will benefit. Not only will therapies become more affordable, but they will also be available faster as the time to market can be shortened.
Replace non-renewable plastics
with plant-based PLA.
You can be part of the transformation of the biotechnology sector by using laboratory consumables made of poly-lactic acid (PLA), a plant-based biopolymer produced entirely from renewable crops.
About Green Elephant Biotech
Green Elephant was founded in 2021 by Dr. Joel Eichmann and Felix Wollenhaupt. Since then, we have been joined by diverse team members from backgrounds in bioprocessing, business development, and marketing. Together, we strive to provide innovative solutions for today’s challenges faced by the biopharmaceutical and biotechnology industries.